Our competitive advantage
Double growth model
Stable organic growth + exponential Deep Tech innovation with high potential
Research ecosystem in Trieste
Researcher density 4 times higher than the EU/US average (37.1/1000), which promotes continuous Deep Tech innovation
First innovation already launched
The ChemoMaker® pharmaceutical robot automates the plug-and-play preparation of chemotherapy treatments in hospital pharmacies (compatible with Becton Dickinson CSTD and Baxter multidose bags), with over 23 units sold in 6 EU countries.
Managing Team
Ing. Diego Bravar | Founder and Chairman
Founder of TBS Group (listed on Milan AIM market), sold for €100 million in 2017 and subsequently resold by the new owner for €1 billion in 2022 (a tenfold increase in value in five years).
Professor at University of Trieste and Confindustria Alto Adriatico Vicepresident.
Solid experience in creating and transforming value.
Ing. Francesco Menegoni | CEO
PhD Bioingegneria Politecnico Milano, fondatore G&Life (partecipata BIP), già esperto Innovazione Presidenza Consiglio (Dipartimento Trasformazione Digitale).
L’eccellenza tecnica incontra la visione strategica.
Dr. Andrea Zacchigna | CFO
Experience in management control and finance at Insiel Mercato and GPI SpA (listed healthcare IT company).
Solid financial expertise in the healthcare sector.